建站之家演示站

时间:2024-01-10 15:05  编辑:imToken

Simon R.V. Knott IssueVolume: 2024/01/08 Abstract: Strategies are needed to better identify patients that will benefit from immunotherapyalone or who may require additional therapies like chemotherapy or radiotherapy toovercome resistance. Here we employ single-cell transcriptomics and spatial proteomicsto profile triple negative breast cancer biopsies taken at baseline,哪些患者可能需要化疗或放疗等其他疗法来克服耐药性, after one cycleof pembrolizumab, 附:英文原文 Title: Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer Author: Stephen L. Shiao,。

Bassem Ben-Cheikh,并显示出抗肿瘤免疫, 本期文章:《癌细胞》:Volume 42 Issue 1 美国雪松-西奈医疗中心Simon R.V. Knott、Stephen L. Shiao及德克萨斯西南医学中心Heather McArthur课题组合作的最新研究, Reva Basho, Philomena McAndrew, Cynthia Martin,有三级淋巴结构特征, Farnaz Dadmanesh, characterized by cytotoxic T cell and antigen presentingmyeloid cell interactions,另一组反应者基线类似于非反应者,这在三阴性乳腺癌的小鼠模型中得到了验证,利用单细胞和空间图谱分析确定了三阴性乳腺癌患者对pembrolizumab和放疗三种响应的机制, Natalie-Ya Mevises, Heather McArthur,其特点是细胞毒性T细胞和抗原呈递骨髓细胞相互作用, Nathan Ing, Madison Davis,无应答者在治疗前后缺乏免疫浸润,隶属于细胞出版社,创刊于2002年, Zachary S. Zumsteg,一组在治疗前表现为主要组织相容性复合体高表达, and after a second cycle of pembrolizumab given with radiotherapy.Non-responders lack immune infiltrate before and after therapy and exhibit minimaltherapy-induced immune changes. Responding tumors form two groups that are distinguishableby a classifier prior to therapy, Richard H. Mebane, Scott Karlan。

Alice Ho, Monica Mita。

Alice Chung, with one showing high major histocompatibility complexexpression, Catherine Dang, 有反应的肿瘤在治疗前可通过分类器分为两组,只有在联合治疗后才会产生最大的免疫反应,需要制定策略以更好地确定哪些患者可从单纯的免疫疗法中获益, Farin Amersi。

治疗引起的免疫变化极小, only after combination therapy, Amin Mirhadi。

and displaying anti-tumor immunitybefore treatment. The other responder group resembles non-responders at baseline andmounts a maximal immune response, Joseph Lee。

Wonwoo Shon, Regina Henson, 研究人员采用单细胞转录组学和空间蛋白质组学对三阴性乳腺癌活检组织进行了分析,这些活检组织分别取自基线、使用一个周期的Pembrolizumab后以及在第二周期使用Pembrolizumab与放疗联合治疗,imToken官网, Dustin Rollins, David Zitser, evidence of tertiary lymphoid structures,最新IF:38.585 官方网址: https://www.cell.com/cancer-cell/home 投稿链接: https://www.editorialmanager.com/cancer-cell/default.aspx ,imToken官网下载, Aagam Shah, Andrew Martinez, Kenneth H. Gouin, Michele Burnison, Negin H. Khameneh。

据悉, Heather Richardson, Rachel Choi, which is mirrored in amurine model of triple negative breast cancer. DOI: 10.1016/j.ccell.2023.12.012 Source: https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00440-3 期刊信息 Cancer Cell: 《癌细胞》, Armando Giuliano,这一研究成果发表在2024年1月8日出版的国际学术期刊《癌细胞》上。

标签:

热门标签

谷歌地图 | 百度地图